NCT02010957 - Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2021

Study Completion Date

July 31, 2022

Conditions

Adrenal Neoplasia

Interventions

OTHER

FDG positron emission tomography

2 consecutive imaging studies (diagnostic study) within 1-2 weeks: FDG-PET and 123I-Iodometomidate imaging in patients with an indeterminate adrenal neoplasm

OTHER

Iodometomidate imaging

2 consecutive imaging studies (diagnostic study) within 1-2 weeks: FDG-PET and 123I-Iodometomidate imaging in patients with an indeterminate adrenal neoplasm

Trial Locations (6)

13353

Charité Universiaetsmedizin, Berlin

45147

Universitaetsklinikum Essen, Essen

55131

Universitaetsmedizin Mainz, Mainz

80336

Klinikum der Universitaet Muenchen, München

97080

University Hospital Wuerzburg, Würzburg

04103

Universitaetsklinik Leipzig, Leipzig